Earnings Feed
Start Free
Home/Filings/4/0001181431-09-018957
4//SEC Filing

BLACKBURN BRENT K 4

Accession 0001181431-09-018957

CIK 0000921506other
View on SEC.govCompany Profile

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 2:16 PM ET

Size

23.9 KB

Accession

0001181431-09-018957

Insider Transaction Report

Form 4
Period: 2009-04-02
CV THERAPEUTICS INCCVTX
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Transactions
  • Exercise/Conversion

    Common Stock

    2009-04-02$13.16/sh+75,000$987,000→ 112,743 total
  • Tax Payment

    Common Stock

    2009-04-02$19.91/sh−59,407$1,182,793→ 53,336 total
  • Exercise/Conversion

    Common Stock

    2009-04-02$13.33/sh+15,000$199,950→ 68,336 total
  • Tax Payment

    Common Stock

    2009-04-02$19.91/sh−11,966$238,243→ 56,370 total
  • Exercise/Conversion

    Common Stock

    2009-04-02$10.45/sh+98,958$1,034,111→ 155,328 total
  • Exercise/Conversion

    Common Stock

    2009-04-02$17.03/sh+25,000$425,750→ 110,708 total
  • Tax Payment

    Common Stock

    2009-04-02$19.91/sh−22,965$457,233→ 87,743 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2009-04-02−15,000→ 0 total
    Exercise: $13.33From: 2007-01-11Exp: 2016-12-11→ Common Stock (15,000 underlying)
  • Tax Payment

    Common Stock

    2009-04-02$19.91/sh−69,620$1,386,134→ 85,708 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2009-04-02−75,000→ 0 total
    Exercise: $13.16From: 2004-01-11Exp: 2013-12-11→ Common Stock (75,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2009-04-02−25,000→ 0 total
    Exercise: $17.03From: 2002-07-07Exp: 2012-06-07→ Common Stock (25,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2009-04-02−98,958→ 88,542 total
    Exercise: $10.45From: 2007-09-22Exp: 2017-08-22→ Common Stock (98,958 underlying)
Holdings

  • Common Stock

    (indirect: By 401(k))
    6,730.908
Footnotes (5)
  • [F1]Shares held in the Reporting Person's name by the Issuer's 401(k) plan.
  • [F2]All shares subject to the option grant were fully vested.
  • [F3]All shares subject to the option grant were fully vested.
  • [F4]1/36th of the shares subject to the option grant shall vest on the 22nd day of each calendar month following August 22, 2007, such that 100% of the shares subject to the option grant are vested on August 22, 2010.
  • [F5]All shares subject to the option grant were fully vested.

Documents

1 file

Issuer

CV THERAPEUTICS INC

CIK 0000921506

→
Entity typeother

Related Parties

1
  • filerCIK 0001238402

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 2:16 PM ET
Size
23.9 KB
View on SEC.gov